Search

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

ADCs have shown their promise, but the next step is realizing their potential.

Join us for an exclusive session on CLIPS™ multicycles, a novel class of constrained tricyclic peptides with enormous potential as next-generation peptide therapeutics.

Ivermectin, Viagra and warfarin; I look at the origins of three popular drugs and the role of serendipity.

Advances in computer simulations allow researchers to look at G protein-coupled receptors in more detail than ever before.

FDA to phase out mandatory animal testing with human-relevant methods for drug development

The 2025 Power List will be available soon!

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.